IART
Price
$12.53
Change
+$0.19 (+1.54%)
Updated
Jan 14 closing price
Capitalization
975.99M
41 days until earnings call
Intraday BUY SELL Signals
RDGL
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Jan 13 closing price
Capitalization
31.65M
Intraday BUY SELL Signals
Interact to see
Advertisement

IART vs RDGL

Header iconIART vs RDGL Comparison
Open Charts IART vs RDGLBanner chart's image
Integra LifeSciences Holdings
Price$12.53
Change+$0.19 (+1.54%)
Volume$652.24K
Capitalization975.99M
Vivos
Price$0.07
Change-$0.00 (-0.00%)
Volume$336.92K
Capitalization31.65M
IART vs RDGL Comparison Chart in %
IART
Daily Signal:
Gain/Loss:
RDGL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IART vs. RDGL commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IART is a Hold and RDGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (IART: $12.53 vs. RDGL: $0.07)
Brand notoriety: IART and RDGL are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: IART: 82% vs. RDGL: 20%
Market capitalization -- IART: $975.99M vs. RDGL: $31.65M
IART [@Medical/Nursing Services] is valued at $975.99M. RDGL’s [@Medical/Nursing Services] market capitalization is $31.65M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $217.36B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IART’s FA Score shows that 1 FA rating(s) are green whileRDGL’s FA Score has 0 green FA rating(s).

  • IART’s FA Score: 1 green, 4 red.
  • RDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, IART is a better buy in the long-term than RDGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IART’s TA Score shows that 2 TA indicator(s) are bullish while RDGL’s TA Score has 4 bullish TA indicator(s).

  • IART’s TA Score: 2 bullish, 7 bearish.
  • RDGL’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RDGL is a better buy in the short-term than IART.

Price Growth

IART (@Medical/Nursing Services) experienced а -4.71% price change this week, while RDGL (@Medical/Nursing Services) price change was +2.45% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +4.93%. For the same industry, the average monthly price growth was +8.56%, and the average quarterly price growth was +22.87%.

Reported Earning Dates

IART is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Medical/Nursing Services (+4.93% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IART($976M) has a higher market cap than RDGL($31.7M). RDGL YTD gains are higher at: 1.887 vs. IART (0.886). RDGL has higher annual earnings (EBITDA): -2.73M vs. IART (-312.71M). IART has more cash in the bank: 268M vs. RDGL (2.2M). RDGL has less debt than IART: RDGL (296K) vs IART (2.01B). IART has higher revenues than RDGL: IART (1.64B) vs RDGL (48.6K).
IARTRDGLIART / RDGL
Capitalization976M31.7M3,079%
EBITDA-312.71M-2.73M11,450%
Gain YTD0.8861.88747%
P/E Ratio66.48N/A-
Revenue1.64B48.6K3,380,658%
Total Cash268M2.2M12,171%
Total Debt2.01B296K677,703%
FUNDAMENTALS RATINGS
IART vs RDGL: Fundamental Ratings
IART
RDGL
OUTLOOK RATING
1..100
105
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
6285
P/E GROWTH RATING
1..100
878
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IART's Valuation (78) in the Medical Specialties industry is in the same range as RDGL (97) in the null industry. This means that IART’s stock grew similarly to RDGL’s over the last 12 months.

IART's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as RDGL (100) in the null industry. This means that IART’s stock grew similarly to RDGL’s over the last 12 months.

IART's SMR Rating (97) in the Medical Specialties industry is in the same range as RDGL (99) in the null industry. This means that IART’s stock grew similarly to RDGL’s over the last 12 months.

IART's Price Growth Rating (62) in the Medical Specialties industry is in the same range as RDGL (85) in the null industry. This means that IART’s stock grew similarly to RDGL’s over the last 12 months.

IART's P/E Growth Rating (8) in the Medical Specialties industry is significantly better than the same rating for RDGL (78) in the null industry. This means that IART’s stock grew significantly faster than RDGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IARTRDGL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
59%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IART
Daily Signal:
Gain/Loss:
RDGL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SDSYA7.500.50
+7.14%
South Dakota Soybean Processors, LLC
VSBC1.00N/A
N/A
VitaSpring Biomedical Co. Ltd.
GRPRF0.70N/A
N/A
GRUPO ROTOPLAS S A B
BIOVF36.58N/A
N/A
Swedish Orphan Biovitrum AB
MCRPF1.48N/A
N/A
Microport Scientific Corp.

IART and

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with ENOV. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
+1.54%
ENOV - IART
58%
Loosely correlated
-1.58%
CNMD - IART
56%
Loosely correlated
+3.87%
RVTY - IART
49%
Loosely correlated
+1.25%
AVNS - IART
46%
Loosely correlated
+4.12%
ZBH - IART
45%
Loosely correlated
+1.02%
More

RDGL and

Correlation & Price change

A.I.dvisor tells us that RDGL and IART have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDGL and IART's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDGL
1D Price
Change %
RDGL100%
+0.72%
IART - RDGL
20%
Poorly correlated
-6.16%
RYLPF - RDGL
8%
Poorly correlated
N/A
SAFLY - RDGL
4%
Poorly correlated
N/A
POSC - RDGL
4%
Poorly correlated
-2.78%
RSMDF - RDGL
-0%
Poorly correlated
+3.39%
More